Form 6-K AEGON NV For: May 12

Article Stock Quotes (2)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. TSLA
3. RDDT
4. TCS:IN
5. ALAB

6. C
7. JPM
8. AAPL
9. GS
10. DJT

Top News Most Read Special Reports

May 12, 2021 8:38 AM EDT

E-mail

Securities and Exchange Commission

Washington, D.C. 20549

Form 6-K

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d/16 of

the Securities Exchange Act of 1934

May 2021

AEGON N.V.

Aegonplein 50

2591 TV THE HAGUE

The Netherlands

Aegon’s condensed consolidated interim financial statements 1Q 2021, dated May 12, 2021, are included as appendix and incorporated herein by reference.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	AEGON N.V.
	(Registrant)

Date: May 12, 2021	By	/s/ J.H.P.M. van Rossum
		J.H.P.M. van Rossum
		Executive Vice President and Head of Corporate Financial Center

LOGO

Condensed consolidated interim financial statements 1Q 2021 Results 1

Table of contents


Condensed consolidated income statement			2

Condensed consolidated statement of comprehensive income			3

Condensed consolidated statement of financial position			4

Condensed consolidated statement of changes in equity			5

Condensed consolidated cash flow statement			6

Notes to the Condensed consolidated interim financial statements			7


Unaudited

2 Condensed consolidated interim financial statements 1Q 2021 Results


Condensed consolidated income statement
EUR millions	Notes		1Q 2021			1Q 2020

Premium income		4		3,958			4,846
Investment income		5		2,093			2,247
Fee and commission income				674			585
Other revenues				-			1
Total revenues				6,725			7,679
Income from reinsurance ceded				920			930
Results from financial transactions		6		1,886			(29,037	)
Other income				41			54
Total income				9,573			(20,373	)

Benefits and expenses		7		9,066			(22,119	)
Impairment charges / (reversals)		8		13			94
Interest charges and related fees				84			118
Other charges				5			86
Total charges				9,167			(21,820	)

Share in profit / (loss) of joint ventures				67			65
Share in profit / (loss) of associates				(15	)		2
Income / (loss) before tax				458			1,514
Income tax (expense) / benefit		9		(72	)		(243	)
Net income / (loss)				386			1,270

Net income / (loss) attributable to:
Owners of Aegon N.V.				383			1,270
Non-controlling interests				3			-

Earnings per share (EUR per share)		13
Basic earnings per common share				0.18			0.61
Basic earnings per common share B				-			0.02
Diluted earnings per common share				0.18			0.61
Diluted earnings per common share B				-			0.02


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 3


Condensed consolidated statement of comprehensive income
EUR millions	Notes	1Q 2021			1Q 2020

Net result			386			1,270

Other comprehensive income:
Items that will not be reclassified to profit or loss:
Changes in revaluation reserve real estate held for own use			-			-
Remeasurements of defined benefit plans			489			588
Income tax relating to items that will not be reclassified			(117	)		(109	)

Items that may be reclassified subsequently to profit or loss:
Gains / (losses) on revaluation of available-for-sale investments			(2,576	)		(1,509	)
Gains / (losses) transferred to the income statement on disposal and impairment of available-for-sale investments			(62	)		19
Changes in cash flow hedging reserve			(138	)		667
Movement in foreign currency translation and net foreign investment hedging reserve			645			234
Equity movements of joint ventures			(2	)		13
Equity movements of associates			(3	)		3
Disposal of group assets			6			(9	)
Income tax relating to items that may be reclassified			593			162
Other			13			1
Total other comprehensive income / (loss) for the period			(1,152	)		59
Total comprehensive income / (loss)			(765	)		1,329

Total comprehensive income / (loss) attributable to:
Owners of Aegon N.V.			(772	)		1,329
Non-controlling interests			7			-


Unaudited

4 Condensed consolidated interim financial statements 1Q 2021 Results


Condensed consolidated statement of financial position
			March 31, 2021	December 31, 2020
EUR millions	Notes

Assets
Cash and cash equivalents			7,247	8,372
Investments		10	154,740	157,595
Investments for account of policyholders		11	233,761	224,172
Derivatives			11,465	13,986
Investments in joint ventures			1,456	1,376
Investments in associates			1,240	1,264
Reinsurance assets			19,765	18,910
Deferred expenses			9,927	8,799
Other assets and receivables			9,623	9,009
Intangible assets			1,457	1,386
Total assets			450,681	444,868

Equity and liabilities
Shareholders’ equity			22,035	22,815
Other equity instruments			2,574	2,569
Issued capital and reserves attributable to owners of Aegon N.V.			24,609	25,384
Non-controlling interests			82	75
Group equity			24,691	25,459

Subordinated borrowings			2,143	2,085
Trust pass-through securities			126	126
Insurance contracts			121,404	122,146
Insurance contracts for account of policyholders			140,537	135,441
Investment contracts			22,201	21,075
Investment contracts for account of policyholders			96,164	91,624
Derivatives			14,004	14,617
Borrowings		14	8,892	8,524
Other liabilities			20,519	23,771
Total liabilities			425,990	419,410

Total equity and liabilities			450,681	444,868


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 5


Condensed consolidated Statement of changes in equity
EUR millions	Share capital ¹		Retained earnings			Revaluation reserves			Remeasurement of defined benefit plans			Other reserves			Other equity instruments		Issued capital and reserves ²			Non- controlling interests			Total

Three months ended March 31, 2021

At beginning of year		7,480		10,943			7,480			(2,534	)		(553	)		2,569		25,384			75			25,459

Net result recognized in the income statement		-		383			-			-			-			-		383			3			386

Other comprehensive income:
*Items that will not be reclassified to profit or loss:*
Remeasurements of defined benefit plans		-		-			-			489			-			-		489			-			489
Income tax relating to items that will not be reclassified		-		-			-			(117	)		-			-		(117	)		-			(117	)

*Items that may be reclassified subsequently to profit or loss:*
Gains / (losses) on revaluation of available-for-sale investments		-		-			(2,576	)		-			-			-		(2,576	)		-			(2,576	)
Gains / (losses) transferred to income statement on disposal and impairment of available-for-sale investments		-		-			(62	)		-			-			-		(62	)		-			(62	)
Changes in cash flow hedging reserve		-		-			(138	)		-			-			-		(138	)		-			(138	)
Movement in foreign currency translation and net foreign investment hedging reserves		-		-			221			(41	)		466			-		645			-			645
Equity movements of joint ventures		-		-			-			-			(2	)		-		(2	)		-			(2	)
Equity movements of associates		-		-			-			-			(3	)		-		(3	)		-			(3	)
Disposal of group assets		-		-			-			-			6			-		6			-			6
Income tax relating to items that may be reclassified		-		-			588			-			5			-		593			-			593
Other		-		9			-			-			-			-		9			4			13
Total other comprehensive income		-		9			(1,967	)		331			471			-		(1,156	)		4			(1,152	)
Total comprehensive income / (loss) for 2021		-		392			(1,967	)		331			471			-		(772	)		7			(765	)

Issuance and purchase of (treasury) shares		-		1			-			-			-			-		1			-			1
Coupons on perpetual securities		-		(9	)		-			-			-			-		(9	)		-			(9	)
Incentive plans		-		-			-			-			-			5		5			-			5
At end of period		7,480		11,328			5,512			(2,203	)		(82	)		2,574		24,609			82			24,691

Three months ended March 31, 2020

At beginning of year		7,536		10,981			5,873			(2,397	)		456			2,571		25,020			20			25,040

Net result recognized in the income statement		-		1,270			-			-			-			-		1,270			-			1,270

Other comprehensive income:
*Items that will not be reclassified to profit or loss:*
Remeasurements of defined benefit plans		-		-			-			588			-			-		588			-			588
Income tax relating to items that will not be reclassified		-		-			-			(109	)		-			-		(109	)		-			(109	)

*Items that may be reclassified subsequently to profit or loss:*
Gains / (losses) on revaluation of available-for-sale investments		-		-			(1,509	)		-			-			-		(1,509	)		-			(1,509	)
Gains / (losses) transferred to income statement on disposal and impairment of available-for-sale investments		-		-			19			-			-			-		19			-			19
Changes in cash flow hedging reserve		-		-			667			-			-			-		667			-			667
Movement in foreign currency translation and net foreign investment hedging reserves		-		-			105			(10	)		140			-		234			-			234
Equity movements of joint ventures		-		-			-			-			13			-		13			-			13
Equity movements of associates		-		-			-			-			3			-		3			-			3
Disposal of group assets		-		-			-			-			(9	)		-		(9	)		-			(9	)
Income tax relating to items that may be reclassified		-		-			167			-			(5	)		-		162			-			162
Other		-		1			-			-			-			-		1			-			1
Total other comprehensive income		-		1			(551	)		468			142			-		59			(0	)		59
Total comprehensive income / (loss) for 2020		-		1,271			(551	)		468			142			-		1,329			-			1,329

Coupons on perpetual securities		-		(10	)		-			-			-			-		(10	)		-			(10	)
Incentive plans		-		-			-			-			-			6		6			-			6
At end of period		7,536		12,243			5,322			(1,929	)		597			2,577		26,346			20			26,366

¹For a breakdown of share capital please refer to note 13.

²Issued capital and reserves attributable to owners of Aegon N.V.


Unaudited

6 Condensed consolidated interim financial statements 1Q 2021 Results


Consolidated cash flow statement
EUR millions	1Q 2021		1Q 2020

Result before tax	458		1,514

Results from financial transactions	(2,490	)	28,991
Amortization and depreciation	274		(64	)
Impairment losses	11		90
Income from joint ventures	(67	)	(65	)
Income from associates	15		(2	)
Release of cash flow hedging reserve	(24	)	(30	)
Other	3		(25	)
Adjustments of non-cash items	(2,278	)	28,896

Insurance and investment liabilities	(1,387	)	1,959
Insurance and investment liabilities for account of policyholders	2,287		(33,363	)
Accrued expenses and other liabilities	(492	)	926
Accrued income and prepayments	(109	)	405
Changes in accruals	298		(30,072	)

Purchase of investments (other than money market investments)	(10,683	)	(12,437	)
Purchase of derivatives	(253	)	822
Disposal of investments (other than money market investments)	12,091		8,193
Disposal of derivatives	(217	)	1,926
Net purchase of investments for account of policyholders	2,398		2,237
Net change in cash collateral	(2,813	)	4,461
Net purchase of money market investments	(502	)	(3,746	)
Cash flow movements on operating items not reflected in income	21		1,455

Tax received / (paid)	37		(25	)
Other	(8	)	(3	)
Net cash flows from operating activities	(1,473	)	1,764
Purchase of individual intangible assets (other than VOBA and future servicing rights)	(9	)	(9	)
Purchase of equipment and real estate for own use	(10	)	(9	)
Acquisition of subsidiaries, net of cash	-		(14	)
Acquisition joint ventures and associates	(9	)	(13	)
Disposal of equipment	-		1
Disposal of subsidiaries, net of cash	57		(1	)
Disposal joint ventures and associates	-		156
Dividend received from joint ventures and associates	9		10
Net cash flows from investing activities	38		122
Proceeds from TRUPS¹, subordinated loans and borrowings	680		733
Repayment of TRUPS¹, subordinated loans and borrowings	(438	)	(1,382	)
Coupons on perpetual securities	(12	)	(13	)
Payment of Right-of-use Assets	(14	)	(15	)
Net cash flows from financing activities	215		(677	)

Net increase / (decrease) in cash and cash equivalents ²	(1,220	)	1,208

Net cash and cash equivalents at the beginning of the reporting period	8,372		12,263
Effects of changes in exchange rate	57		-
Net cash and cash equivalents at the end of the reporting period	7,209		13,472

¹ Trust pass-through securities

² Included in net increase / (decrease) in cash and cash equivalents are interest received EUR 1,451 million (2020: EUR 1,223 million) dividends received EUR 756 million (2020: EUR 806 million) and interest paid EUR 9 million (2020: EUR 76 million). All included in operating activities except for dividend received from joint ventures and associates EUR 9 million (2020: EUR 10 million).


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 7

Notes to the Condensed consolidated interim financial statements

Amounts in EUR millions, unless otherwise stated

Aegon N.V., incorporated and domiciled in the Netherlands, is a public limited liability company organized under Dutch law and recorded in the Commercial Register of The Hague under number 27076669 and with its registered address at Aegonplein 50, 2591 TV, The Hague, the Netherlands. Aegon N.V. serves as the holding company for the Aegon Group and has listings of its common shares in Amsterdam and New York.

Aegon N.V. (or ‘the Company’) and its subsidiaries (collectively, ‘Aegon’ or ‘the Group’) have life insurance and pensions operations in more than 20 countries in the Americas, Europe and Asia and are also active in savings and asset management operations, accident and health insurance, general insurance and - to a limited extent - banking operations. Headquarters are located in The Hague, the Netherlands. The Group employs over 22,000 people worldwide.

1. Basis of presentation

The condensed consolidated interim financial statements as at, and for the three-month period ended, March 31, 2021 (‘first quarter 2021’ or ‘1Q 2021’), have been prepared in accordance with IAS 34 ‘Interim Financial Reporting’, as adopted by the European Union (hereafter ‘IFRS-EU’). They do not include all of the information required for a full set of financial statements prepared in accordance with IFRS-EU and should therefore be read together with the 2020 consolidated financial statements of Aegon N.V. as included in Aegon’s Integrated Annual Report for 2020. Aegon’s Integrated Annual Report for 2020 is available on its website (aegon.com).

The condensed consolidated interim financial statements have been prepared in accordance with the historical cost convention as modified by the revaluation of investment properties and those financial instruments (including derivatives) and financial liabilities that have been measured at fair value. The condensed consolidated interim financial statements as at, and for the three-month period ended, March 31, 2021, were approved by the Supervisory Board on May 11, 2021.

The condensed consolidated interim financial statements are presented in euro (EUR) and all values are rounded to the nearest million unless otherwise stated. The consequence is that the rounded amounts may not add up to the rounded total in all cases.

The published figures in these condensed consolidated interim financial statements are unaudited.

2. Significant accounting policies

All accounting policies and methods of computation applied in the condensed consolidated interim financial statements are the same as those applied in the 2020 consolidated financial statements. New IFRS accounting standards and amendments that became effective per January 1, 2021 had no impact on Aegon’s financial position or condensed consolidated interim financial statements (refer to paragraph 2.1).

2.1. New IFRS accounting standards effective from 2021

In August 2020, the IASB issued the ‘Interest Rate Benchmark Reform – Phase 2 (Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16)’. The Phase 2 amendments provide temporary reliefs which address issues that might affect financial reporting during the interest rate benchmark reform, including the effects of changes to contractual cash flows or hedging relationships arising from the replacement of an interest rate benchmark with an alternative benchmark rate. The Phase 2 amendments became effective in 2021 and have been endorsed by the European Union.

The Phase 2 amendments had no impact on Aegon’s financial position or condensed consolidated interim financial statements. Aegon continues to follow the developments of interest rate benchmark reform and intends to use the Phase 2 reliefs when applicable.


Unaudited

8 Condensed consolidated interim financial statements 1Q 2021 Results

2.2. Future adoption of new IFRS-EU accounting standards and amendments

For a complete overview of IFRS standards and amendments issued before January 1, 2021, which will be applied in future years and were not early adopted by the Group, please refer to Aegon’s Integrated Annual Report for 2020.

In February 2021, the IASB issued the following amendments:

Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2); and

Definition of Accounting Estimates (Amendments to IAS 8).

These amendments are effective for annual reporting periods beginning on or after January 1, 2023, with early application permitted and have not been endorsed by the European Union. Aegon is assessing the impact of these amendments.

In March 2021, the IASB issued the ‘Covid-19-Related Rent Concessions beyond 30 June 2021 (Amendment to IFRS 16)’. The amendment is effective for annual reporting periods beginning on or after April 1, 2021, with early application permitted and has not been endorsed by the European Union. Impact of this amendment is not expected to be significant.

2.3. Judgments and critical accounting estimates

Preparing the condensed consolidated interim financial statements requires management to make judgments, estimates and assumptions, including the likelihood, timing or amount of future transactions or events, that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. These estimates are inherently subject to change and actual results could differ from those estimates.

Uncertainty resulting from COVID-19

During 1Q 2021 the COVID-19 pandemic continued to cause significant disruption to business, markets, and the industry. In 1Q 2021 Aegon’s operating result in the Americas was impacted by USD 166 million of adverse mortality in Life, of which USD 95 million of claims are directly attributable to COVID-19 as the cause of death. This was offset by favorable morbidity experience in Accident & Health and is mostly related to Long-Term Care insurance with higher claims terminations due to higher mortality and discharges from care facilities. As soon as the impacts of the COVID-19 pandemic subside, Aegon expects the number of new Long-Term care claims to reverse. Aegon continues to monitor the relevant market and the economic factors to proactively manage the associated risks. Management believes that the most significant risks are related to financial markets (particularly credit, equity, and interest rates risks) and underwriting risks (particularly related to mortality, morbidity, and policyholder behavior).

Actuarial and economic assumptions

Aegon the Netherlands has updated the indexation assumption for a specific pensions portfolio linked to Dutch industry pension funds after a sharp rise of the price inflation curve. Instead of a historical analysis, the substantiation of the updated indexation assumption will be based on a new forward-looking method that also takes into account the drivers (coverage ratio, asset mix, expected returns) for indexation pay-out by industry pension funds. The updated indexation assumption resulted in a lower market value liability of EUR 75 million. The release of the liability has been recorded as part of Benefits and expenses and in Other income for segment reporting purposes.

Sensitivities

Sensitivity on variable annuities and variable life insurance products in the United States

Sensitivities of Aegon’s variable annuities and variable life insurance products in the United States on expected long-term equity growth rate have not significantly changed compared to the sensitivities as reported in the Aegon’s 2020 Integrated Annual Report, except for sensitivities to mortality assumption and lapse rate.

A relative increase of 10% to the mortality assumption, dependent on product and characteristics of the block of business, would reduce net result by approximately EUR 181 million (December 31, 2020: EUR 124 million). A relative 20% increase in the lapse rate assumption would increase net result by approximately EUR 38 million (December 31, 2020: EUR 89 million).


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 9

Sensitivity on liability adequacy test (LAT) in the Netherlands

At March 31, 2021 the liability adequacy test (LAT) of Aegon the Netherlands remains in a deficit position. The LAT assesses the adequacy of the insurance liabilities by comparing them to their fair value. Aegon the Netherlands adjusts the outcome of the LAT for certain unrealized gains in the bond portfolio and certain differences between the fair value and the book value of assets measured at amortized cost, mainly residential mortgages. Please also refer to Note 2.19f Liability adequacy testing of Aegon’s 2020 Integrated Annual Report for further details on the accounting policy.

The LAT deficit per March 31, 2021 in Aegon the Netherlands amounted to EUR 4.8 billion (December 31, 2020: EUR 7.0 billion), which was partially offset by the shadow loss recognition of EUR 3.5 billion (December 31, 2020: EUR 4.5 billion), resulting in a net deficit of EUR 1.3 billion (December 31, 2020: EUR 2.5 billion). The improvement of the LAT deficit amounting to EUR 1.2 billion is driven by market movements (mainly increased interest rates and tightening of credit spreads) and is recorded in the income statement for the first quarter 2021.

Sensitivities of Aegon the Netherlands on bond credit spread, mortgage spread and liquidity premium assumptions to assess the impact on the LAT test have not significantly changed compared to the sensitivities as reported in the 2020 Aegon’s Integrated Annual Report, except for sensitivities to interest rate. An increase of 100 bps in interest rate would result in a decrease in the LAT deficit of EUR 3.2 billion (December 31, 2020: EUR 3.9 billion). A decrease of 100 bps would result in an increase in the LAT deficit of approximately EUR 4.3 billion (2019: EUR 5.2 billion).

2.4. Other

Taxes

Taxes on income for the three-month period ended March 31, 2021, are calculated using the tax rate that is estimated to be applicable to earnings for the full year.

Exchange rates

Assets and liabilities of foreign operations are translated to the presentation currency at the closing rates on the reporting date. Income, expenses and capital transactions (such as dividends) are translated at average exchange rates or at the prevailing rates on the transaction date, if more appropriate. The following exchange rates (most important rates) are applied for the condensed consolidated interim financial statements:


Closing exchange rates


			USD	GBP
March 31, 2021	1	EUR	1.1753	0.8519
December 31, 2020	1	EUR	1.2236	0.8951

Weighted average exchange rates


			USD	GBP
Three months ended March 31, 2021	1	EUR	1.2046	0.8737
Three months ended March 31, 2020	1	EUR	1.1026	0.8612


Unaudited

10 Condensed consolidated interim financial statements 1Q 2021 Results

3. Segment information

3.1. Change in name convention of performance measure

Aegon has changed the name convention of its primary performance measure to improve alignment with industry practice. As of 2021, Aegon will no longer refer to underlying earnings before tax for segment reporting purposes, instead Aegon will refer to Operating result. Furthermore, Aegon introduced a new grouping of non-operating result which is the sum of Fair value items, Realized gains / (losses) on investments, and Net impairments. Other income / charges remains a separate category outside of Aegon’s operating result.

3.2. Change in measurement of performance measure

In addition, Aegon has changed the measurement of its operating result from January 1, 2021. The following changes have been made:

1.	The running cost of the US macro hedge related to the variable annuity portfolio are recorded within Operating result instead of in Fair value items. Management views this as a better reflection of Aegon’s operating performance and will make Aegon’s operating result more relevant.

2.	The periodic intangibles unlocking in the US Life and TLB business is recorded in Fair value items, instead of Operating result, to improve the insight in Aegon’s recurring operating result.

Results from run-off businesses in the US are part of Aegon’s operating result. The results of run-off businesses were previously recorded outside of Aegon’s operating result. Based on management actions executed in prior years the importance of run-off businesses has diminished and continuing to report this as a separate line item is considered no longer relevant.

4.	Following the announcement to sell Aegon’s operations in CEE, results from these businesses, previously reported in operating result, are prospectively recorded within Other income / charges.

For segment reporting purposes, the impact of these changes in measurement on 1Q 2020 was a decrease in Aegon’s consolidated operating result of EUR 8 million, as certain losses are no longer reported in Fair value items (EUR 5 million) and results of Run-off businesses are no longer separately reported (EUR 3 million loss). There is no impact on Aegon’s net result, shareholders’ equity, dividend per share, or any of the main schedules included in Aegon’s Condensed Consolidated Interim Financial Statements, in any of the reporting periods. Comparative numbers have been restated in Aegon’s segment reporting note, enabling a like for like comparison, with the exception of the reclassification of the results from Aegon’s operations in CEE to Other income / charges which is applied prospectively.


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 11

3.3. Segment results

The following table presents Aegon’s segment results.


EUR millions	Americas			The Netherlands			United Kingdom			International			Asset management			Holdings and other activities			Eliminations			Segment total			Joint ventures and associates eliminations			Consolidated
*Three months ended March 31, 2021*

Operating result geographically		163			184			39			28			75			(58	)		(1	)		431			(43	)		388
Fair value items		(52	)		71			(48	)		-			(2	)		34			2			3			19			22
Realized gains / (losses) on investments		21			9			-			-			2			-			-			31			(3	)		28
Impairment charges		(4	)		2			-			-			-			7			-			6			-			6
Impairment reversals		9			1			-			-			-			-			-			10			-			10
Non-operating items		(25	)		82			(48	)		-			(1	)		41			2			50			16			66
Other income / (charges)		(7	)		33			(3	)		15			(2	)		(35	)		-			1			3			4
Result before tax		131			299			(12	)		43			72			(52	)		1			482			(24	)		458
Income tax (expense) / benefit		(8	)		(71	)		-			(7	)		(21	)		10			-			(96	)		24			(72	)
Net result		123			228			(11	)		36			52			(42	)		1			386			-			386
Inter-segment operating result after tax		(7	)		(22	)		(22	)		(8	)		46			12

Revenues
Life insurance gross premiums		1,691			392			1,143			340			-			-			-			3,566			(255	)		3,311
Accident and health insurance		315			142			3			119			-			-			-			579			(33	)		547
Property & casualty insurance		-			33			-			107			-			-			-			140			(40	)		100
Total gross premiums		2,006			568			1,146			566			-			-			-			4,285			(327	)		3,958
Investment income		705			501			819			88			2			59			(64	)		2,110			(17	)		2,093
Fee and commission income		473			72			51			14			213			-			(44	)		779			(104	)		674
Other revenues		2			-			-			1			-			-			-			3			(3	)		-
Total revenues		3,186			1,140			2,015			669			216			59			(108	)		7,177			(451	)		6,725
Inter-segment revenues		-			4			-			-			44			60


EUR millions	Americas			The Netherlands			United Kingdom			International			Asset management			Holdings and other activities			Eliminations			Segment total			Joint ventures and associates eliminations			Consolidated
*Three months ended March 31, 2020*

Operating result geographically		129			154			44			49			38			(58	)		2			358			8			366
Fair value items		(650	)		1,931			145			(6	)		(15	)		(28	)		-			1,377			(20	)		1,357
Realized gains / (losses) on investments		11			3			-			-			-			-			-			14			(4	)		10
Impairment charges		(40	)		(20	)		-			(2	)		-			(4	)		-			(66	)		-			(66	)
Impairment reversals		8			(1	)		-			-			-			-			-			7			-			7
Non-operating items		(672	)		1,914			145			(3	)		(15	)		(37	)		-			1,333			(24	)		1,309
Other income / (charges)		(109	)		(12	)		(62	)		52			-			(32	)		-			(162	)		1			(161	)
Result before tax		(652	)		2,057			128			93			23			(122	)		2			1,529			(15	)		1,514
Income tax (expense) / benefit		161			(425	)		(5	)		(8	)		(7	)		27			-			(258	)		15			(243	)
Net result		(492	)		1,632			122			85			16			(95	)		2			1,270			-			1,270
Inter-segment operating result after tax		(11	)		(22	)		(22	)		(8	)		47			17

Revenues
Life insurance gross premiums		1,824			650			1,569			365			-			3			(2	)		4,409			(269	)		4,140
Accident and health insurance		362			137			7			124			-			-			-			630			(26	)		604
Property & casualty insurance		-			32			-			104			-			-			-			136			(35	)		102
Total gross premiums		2,185			820			1,576			593			-			3			(2	)		5,175			(329	)		4,846
Investment income		805			495			871			94			1			64			(69	)		2,262			(15	)		2,247
Fee and commission income		394			65			50			14			170			-			(46	)		647			(62	)		585
Other revenues		2			-			-			-			-			1			-			4			(3	)		1
Total revenues		3,387			1,380			2,497			701			172			68			(116	)		8,088			(409	)		7,679
Inter-segment revenues		-			4			-			-			46			67

Aegon’s segment information is prepared by consolidating on a proportionate basis Aegon’s joint ventures and associated companies.


Unaudited

12 Condensed consolidated interim financial statements 1Q 2021 Results

3.4. Investments

Amounts included in the tables on investments are presented on an IFRS basis, which means that investments in joint ventures and associates are not consolidated on a proportionate basis. Instead, these investments are included on a single line using the equity method of accounting.


March 31, 2021	Americas		The Netherlands		United Kingdom		International		Asset Management		Holding and other activities		Eliminations			EUR Millions Total
Investments
Shares		476		1,387		27		74		8		41		-			2,013
Debt securities		57,976		27,924		1,200		7,804		51		1		-			94,956
Loans		10,999		35,233		-		110		-		40		-			46,382
Other financial assets		7,982		94		744		118		95		18		-			9,050
Investments in real estate		39		2,283		-		16		-		-		-			2,338
Investments general account		77,471		66,921		1,971		8,123		154		100		-			154,740
Shares		-		8,670		17,737		234		-		-		(4	)		26,638
Debt securities		-		11,942		7,524		146		-		-		-			19,612
Unconsolidated investment funds		109,134		781		67,382		606		-		-		-			177,903
Other financial assets		-		3,883		5,228		2		-		-		-			9,113
Investments in real estate		-		-		496		-		-		-		-			496
Investments for account of policyholders		109,134		25,276		98,367		988		-		-		(4	)		233,761
Investments on balance sheet		186,605		92,197		100,338		9,111		154		100		(4	)		388,501
Off balance sheet investments third parties		224,194		6,370		127,977		2,037		191,542		-		-			552,120
Total revenue generating investments		410,800		98,567		228,315		11,147		191,696		100		(4	)		940,621
Investments
Available-for-sale		63,200		26,584		1,398		7,987		75		27		-			99,271
Loans		10,999		35,233		-		110		-		40		-			46,382
Financial assets at fair value through profit or loss		112,367		28,097		98,445		997		79		32		(4	)		240,014
Investments in real estate		39		2,283		496		16		-		-		-			2,833
Total investments on balance sheet		186,605		92,197		100,338		9,111		154		100		(4	)		388,501
Investments in joint ventures		-		332		-		868		257		-		-			1,456
Investments in associates		58		982		8		31		153		21		(14	)		1,240
Other assets		35,357		15,550		5,425		2,773		461		31,836		(31,918	)		59,484
Consolidated total assets		222,020		109,061		105,772		12,782		1,025		31,957		(31,936	)		450,681


December 31, 2020	Americas		The Netherlands		United Kingdom		International		Asset Management		Holding and other activities		Eliminations			EUR Millions Total
Investments
Shares		442		1,376		34		74		9		44		-			1,979
Debt securities		59,419		30,880		1,077		7,926		48		1		-			99,350
Loans		10,477		34,936		-		120		-		40		-			45,573
Other financial assets		7,056		91		883		102		152		23		-			8,308
Investments in real estate		37		2,331		-		16		-		-		-			2,385
Investments general account		77,431		69,615		1,994		8,238		208		108		-			157,595
Shares		-		8,227		16,877		187		-		-		(3	)		25,288
Debt securities		-		12,150		7,579		156		-		-		-			19,885
Unconsolidated investment funds		104,374		706		63,084		613		-		-		-			168,777
Other financial assets		-		4,520		5,232		3		-		-		-			9,755
Investments in real estate		-		-		467		-		-		-		-			467
Investments for account of policyholders		104,374		25,603		93,240		959		-		-		(3	)		224,172
Investments on balance sheet		181,805		95,218		95,234		9,197		208		108		(3	)		381,767
Off balance sheet investments third parties		215,216		6,144		119,347		6,752		192,098		-		(336	)		539,220
Total revenue generating investments		397,021		101,362		214,580		15,948		192,307		108		(339	)		920,987
Investments
Available-for-sale		63,864		25,972		1,494		8,088		134		28		-			99,580
Loans		10,477		34,936		-		120		-		40		-			45,573
Financial assets at fair value through profit or loss		107,427		31,979		93,272		973		74		40		(3	)		233,762
Investments in real estate		37		2,331		467		16		-		-		-			2,853
Total investments on balance sheet		181,805		95,218		95,234		9,197		208		108		(3	)		381,767
Investments in joint ventures		-		327		-		846		204		-		-			1,376
Investments in associates		60		1,004		8		35		151		21		(15	)		1,264
Other assets		35,010		19,467		3,740		2,405		545		32,695		(33,400	)		60,461
Consolidated total assets		216,875		116,016		98,982		12,482		1,109		32,824		(33,419	)		444,868


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 13

4. Premium income and premiums paid to reinsurers



EUR millions	1Q 2021		1Q 2020

Premium income
Life insurance		3,311		4,140
Non-life insurance		647		705
Total premium income		3,958		4,846
Accident and health insurance		547		604
Property & casualty insurance		100		102
Non-life Insurance premium income		647		705

Premiums paid to reinsurers ¹
Life insurance		497		554
Non-life insurance		47		43
Total premiums paid to reinsurers		545		597
Accident and health insurance		40		36
Property & casualty insurance		7		6
Non-life Insurance paid to reinsurers		47		43

Premium income decreased by EUR 888 million in 1Q 2021 compared to 1Q 2020, mainly driven by a reduction of upgraded Life insurance policies to the retirement platform in the UK, reduced new business related to COVID-19, and impacts of foreign currency translation.

5. Investment income



EUR millions	1Q 2021		1Q 2020

Interest income		1,297		1,407
Dividend income		772		807
Rental income		24		32
Total investment income		2,093		2,247

Investment income related to general account		1,186		1,286
Investment income for account of policyholders		907		961
Total		2,093		2,247


Unaudited

14 Condensed consolidated interim financial statements 1Q 2021 Results

6. Results from financial transactions



EUR millions	1Q 2021			1Q 2020

Net fair value change of general account financial investments at FVTPL other than derivatives		54			(199	)
Realized gains /(losses) on financial investments		39			6
Gains /(losses) on investments in real estate		(43	)		57
Net fair value change of derivatives		(1,011	)		(1,139	)
Net fair value change on for account of policyholder financial assets at FVTPL		2,710			(27,759	)
Net fair value change on investments in real estate for account of policyholders		3			(19	)
Net foreign currency gains /(losses)		135			9
Net fair value change on borrowings and other financial liabilities		-			7
Total		1,886			(29,037	)

Net fair value change on for account of policyholder financial assets at fair value through profit or loss increased in 1Q 2021 compared to 1Q 2020, mainly from favorable equity markets. Net fair value changes on for account of policyholder financial assets at fair value through profit or loss are offset by changes in technical provisions reported as part of the lines “Change in valuation of liabilities for insurance contracts” and “Change in valuation of liabilities for investment contracts” in note 7 Benefits and expenses.

7. Benefits and expenses



EUR millions	1Q 2021			1Q 2020

Claims and benefits		8,141			(23,103	)
Employee expenses		490			521
Administration expenses		376			404
Deferred expenses		(146	)		(205	)
Amortization charges		205			265
Total		9,066			(22,119	)


EUR millions	1Q 2021			1Q 2020

Benefits and claims paid life		6,263			1,514
Benefits and claims paid non-life		347			414
Change in valuation of liabilities for insurance contracts		769			(18,089	)
Change in valuation of liabilities for investment contracts		(357	)		(8,155	)
Other		(2	)		27

Policyholder claims and benefits		7,019			(24,289	)
Premium paid to reinsurers		545			597
Profit sharing and rebates		2			3
Commissions		576			587
Total		8,141			(23,103	)

The lines “Change in valuation of liabilities for insurance contracts” and “Change in valuation of liabilities for investment contracts” reflect changes in technical provisions resulting from “Net fair value changes on for account of policyholder financial assets at fair value through profit or loss” included in note 6 Results from financial transactions of EUR 2,710 million positive for 1Q 2021 (1Q 2020: EUR 27,759 million negative). In addition, the line “Change in valuation of liabilities for insurance contracts” includes a decrease of technical provisions for life insurance contracts of EUR 1,083 million for 1Q 2021 (1Q 2020: increase of EUR 2,861 million).


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 15

8. Impairment charges/(reversals)



EUR millions	1Q 2021			1Q 2020

Impairment charges / (reversals) comprise:
Impairment charges / (reversals) on financial assets, excluding receivables		(6	)		59
Impairment charges / (reversals) on non-financial assets and receivables		19			35
Total		13			94

Impairment charges on financial assets, excluding receivables, from:
Shares		-			4
Debt securities and money market instruments		3			43
Loans		10			19
Total		13			66

Impairment reversals on financial assets, excluding receivables, from:
Shares		(8	)		-
Debt securities and money market instruments		(10	)		(7	)
Loans		(1	)		1
Total		(19	)		(7	)

Impairment charges on non-financial assets and receivables in the first quarter of 2021 amount to EUR 19 million and are mainly related to a valuation allowance due to the ongoing rehabilitation process of a US reinsurer.

9. Income tax

The income tax charge for 1Q 2021 amounts to EUR 72 million which includes recurring beneficial impacts of tax-exempt income and US tax credits. Non-taxable income in 1Q 2021 is comprised of the regular non-taxable items such as the dividend received deduction in the United States and the participation exemption in the Netherlands.

Tax credits mainly include tax benefits from United States investments that provide affordable housing to individuals and families that meet median household income requirements.


Unaudited

16 Condensed consolidated interim financial statements 1Q 2021 Results

10. Investments



EUR millions	March 31, 2021		December 31, 2020

Available-for-sale (AFS)		99,271		99,580
Loans		46,382		45,573
Financial assets at fair value through profit or loss (FVTPL)		6,748		10,057
Financial assets, for general account, excluding derivatives		152,402		155,210
Investments in real estate		2,338		2,385
Total investments for general account, excluding derivatives		154,740		157,595



Financial assets, for general account, excluding derivatives
EUR millions	AFS		FVTPL		Loans		Total

Shares		373		1,641		-		2,013
Debt securities		92,762		2,194		-		94,956
Money market and other short-term investments		5,249		122		-		5,371
Mortgages loans		-		-		40,050		40,050
Private loans		-		-		4,370		4,370
Deposits with financial institutions		-		-		81		81
Policy loans		-		-		1,860		1,860
Receivables out of share lease agreements		-		-		-		-
Other
Other		887		2,792		22		3,701
March 31, 2021		99,271		6,749		46,382		152,402

	AFS		FVTPL		Loans		Total

Shares		345		1,634		-		1,979
Debt securities		93,681		5,669		-		99,350
Money market and other short-term investments		4,558		109		-		4,667
Mortgages loans		-		-		39,298		39,298
Private loans		-		-		4,358		4,358
Deposits with financial institutions		-		-		92		92
Policy loans		-		-		1,801		1,801
Receivables out of share lease agreements		-		-		-		-
Other
Other		996		2,645		25		3,665
December 31, 2020		99,580		10,057		45,573		155,210

Total investments for general account, excluding derivatives amount to EUR 154.7 billion (December 31, 2020: EUR 157.6 billion). The decrease is mainly due to increased interest rates in Americas and the Netherlands, partially offset by the positive impact of foreign currency translations.


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 17

11. Investments for account of policyholders



EUR millions	March 31, 2021		December 31, 2020
Shares		26,638		25,288
Debt securities		19,612		19,885
Money market and short-term investments		1,643		1,051
Deposits with financial institutions		3,587		4,185
Unconsolidated investment funds		177,903		168,777
Other		3,883		4,520
Total investments for account of policyholders at fair value through profit or loss, excluding derivatives		233,266		223,705
Investment in real estate		496		467
Total investments for account of policyholders		233,761		224,172

Investments for account of policyholders amount to EUR 233.8 billion (December 31, 2020: EUR 224.2 billion). The increase is mainly due to the positive impact of foreign currency translations and positive market movements.

12. Fair value

The following tables provide an analysis of financial instruments recorded at fair value on a recurring basis by level of the fair value hierarchy:


Fair value hierarchy
EUR millions	March 31, 2021									December 31, 2020
	Level I		Level II		Level III			Total		Level I		Level II		Level III			Total

Financial assets carried at fair value
Available-for-sale investments
Shares		93		86		193			373		90		82		173			345
Debt securities		25,692		66,418		652			92,762		28,300		64,914		467			93,681
Money markets and other short-term instruments		1,400		3,849		-			5,249		832		3,726		-			4,558
Other investments at fair value		-		299		588			887		-		415		581			996
Total Available-for-sale investments		27,185		70,652		1,434			99,271		29,222		69,136		1,221			99,580

Fair value through profit or loss
Shares		89		218		1,334			1,641		80		226		1,329			1,634
Debt securities		118		2,044		32			2,194		168		5,260		242			5,669
Money markets and other short-term instruments		18		104		-			122		17		93		-			109
Other investments at fair value		1		412		2,379			2,792		1		470		2,174			2,645
Investments for account of policyholders ¹		122,735		109,764		766			233,266		118,057		104,635		1,012			223,705
Derivatives		59		11,401		5			11,465		34		13,930		22			13,986
Total Fair value through profit or loss		123,020		123,943		4,516			251,479		118,356		124,613		4,779			247,748
Total financial assets at fair value		150,205		194,596		5,950			350,751		147,578		193,750		6,000			347,327

Financial liabilities carried at fair value
Investment contracts for account of policyholders ²		-		63,511		(108	)		63,403		-		59,637		(12	)		59,625
Derivatives		36		10,952		3,016			14,004		61		9,654		4,902			14,617
Total financial liabilities at fair value		36		74,463		2,908			77,407		61		69,291		4,890			74,242

¹ The investments for account of policyholders included in the table above represents only those investments carried at fair value through profit or loss.

² The investment contracts for account of policyholders included in the table above represents only those investment contracts carried at fair value.

³ Total borrowings on the statement of financial position contain borrowings carried at amortized cost that are not included in the above schedule.

Significant transfers between Level I, Level II and Level III

The table below shows transfers between Level I and Level II for financial assets and financial liabilities recorded at fair value on a recurring basis.

Fair value transfers

EUR millions

March 31,

2021

December 31,

2020

Transfers

Level I to

Level II

Transfers

Level II to

Level I

Transfers

Level I to

Level II

Transfers

Level II to
Level I

Financial assets carried at fair value

Available-for-sale investments

Debt securities

106

131

Total

106

131

Transfers are identified based on transaction volume and frequency, which are indicative of an active market.


Unaudited

18 Condensed consolidated interim financial statements 1Q 2021 Results

Movements in Level III financial instruments measured at fair value

The following table summarizes the change of all assets and liabilities measured at estimated fair value on a recurring basis using significant unobservable inputs (‘Level III’), including realized and unrealized gains (losses) of all assets and liabilities and unrealized gains (losses) of all assets and liabilities still held at the end of the respective period.


Roll forward of Level III financial instruments
EUR millions	January 1, 2021			Total gains / losses in income statement¹			Total gains / losses in OCI²			Purchases			Sales			Settlements			Net exchange differences			Transfers from Level I and Level II		Transfers to Level I and Level II			March 31, 2021			Total unrealized gains and losses for the period recorded in the P&L for instruments held at March 31, 2021 ³
Financial assets carried at fair value available-for-sale investments
Shares		173			-			(2	)		16			-			-			6			-		-			193			-
Debt securities		467			(2	)		(10	)		187			(6	)		(6	)		12			60		(50	)		652			-
Other investments at fair value		581			(31	)		(1	)		19			(1	)		(2	)		23			-		-			588			-
		1,221			(33	)		(13	)		222			(7	)		(8	)		41			60		(50	)		1,434			-

Fair value through profit or loss
Shares		1,329			65			-			23			(84	)		-			1			-		-			1,334			65
Debt securities		242			-			-			30			(239	)		-			-			-		-			32			-
Other investments at fair value		2,173			68			-			103			(55	)		-			89			-		-			2,379			(3	)
Investments for account of policyholders		1,012			(188	)		-			(125	)		51			-			16			-		-			766			(467	)
Derivatives		22			(17	)		-			-			-			-			-			-		-			5			(17	)
		4,779			(72	)		-			31			(328	)		-			106			-		-			4,516			(422	)

Financial liabilities carried at fair value
Investment contracts for account of policyholders		(12	)		(80	)		-			(26	)		9			-			1			-		-			(108	)		163
Derivatives		4,902			(1,960	)		-			-			(3	)		-			77			-		-			3,016			335
		4,890			(2,040	)		-			(26	)		6			-			78			-		-			2,908			498


EUR millions	January 1, 2020			Total gains / losses in income statement¹			Total gains / losses in OCI²			Purchases			Sales			Settlements			Net exchange differences			Transfers from Level I and Level II		Transfers to Level I and Level II			December 31, 2020			Total unrealized gains and losses for the period recorded in the P&L for instruments held at December 31, 2020 ³
Financial assets carried at fair value available-for-sale investments
Shares		157			(27	)		24			49			(15	)		(1	)		(12	)		-		(2	)		173			-
Debt securities		1,074			3			(19	)		155			(11	)		(34	)		(32	)		26		(695	)		467			-
Other investments at fair value		482			(140	)		28			302			(19	)		(22	)		(50	)		-		-			581			-
		1,712			(163	)		34			505			(45	)		(56	)		(94	)		26		(697	)		1,221			-

Fair value through profit or loss
Shares		1,401			(132	)		-			160			(97	)		-			(3	)		-		-			1,329			(98	)
Debt securities		4			-			-			276			(37	)		-			-			-		-			242			-
Other investments at fair value		2,049			122			-			432			(250	)		-			(184	)		16		(13	)		2,173			(1	)
Investments for account of policyholders		1,805			3			-			(168	)		(607	)		-			(20	)		-		-			1,012			37
Derivatives		56			(33	)		-			-			-			-			-			-		-			22			(32	)
		5,314			(40	)		-			700			(991	)		-			(207	)		16		(13	)		4,779			(93	)

Financial liabilities carried at fair value
Investment contracts for account of policyholders		197			9			-			(200	)		(16	)		-			(3	)		-		-			(12	)		7
Derivatives		3,081			2,073			(9	)		-			(15	)		-			(228	)		-		-			4,902			314
		3,278			2,082			(9	)		(200	)		(31	)		-			(231	)		-		-			4,890			321

¹ Includes impairments and movements related to fair value hedges. Gains and losses are recorded in the line item results from financial transactions of the income statement.

² Total gains and losses are recorded in line items Gains/ (losses) on revaluation of available-for-sale investments and (Gains)/ losses transferred to the income statement on disposal and impairment of available-for-sale investment of the statement of other comprehensive income.

³ Total gains / (losses) for the period during which the financial instrument was in Level III.

Fair value information about financial instruments not measured at fair value

The following table presents the carrying values and estimated fair values of financial assets and liabilities, excluding financial instruments which are carried at fair value on a recurring basis.


Fair value information about financial instruments not measured at fair value
	Carrying amount		Total estimated fair value		Carrying amount		Total estimated fair value
EUR millions	March 31, 2021				December 31, 2020

Assets
Mortgage loans - held at amortized cost		40,050		44,030		39,298		43,258
Private loans - held at amortized cost		4,370		5,080		4,358		5,280
Other loans - held at amortized cost		1,963		1,963		1,917		1,917

Liabilities
Subordinated borrowings - held at amortized cost		2,143		2,359		2,085		2,351
Trust pass-through securities - held at amortized cost		126		139		126		142
Borrowings – held at amortized cost		8,892		9,331		8,524		9,165
Investment contracts - held at amortized cost		22,007		21,210		20,889		20,382

Financial instruments for which carrying value approximates fair value

Certain financial instruments that are not carried at fair value are carried at amounts that approximate fair value, due to their short-term nature and generally negligible credit risk. These instruments include cash and cash equivalents, short-term receivables and accrued interest receivable, short-term liabilities, and accrued liabilities. These instruments are not included in the table above.


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 19

13. Share capital



EUR millions	March 31, 2021		December 31, 2020
Share capital - par value		320		320
Share premium		7,160		7,160
Total share capital		7,480		7,480

Share capital - par value
Balance at January 1		320		323
Dividend		-		-
Shares withdrawn		-		(3	)
Balance		320		320


Share premium
Balance at January 1	7,160	7,213
Share dividend	-	(54	)
Balance	7,160	7,160



EUR millions	1Q 2021			1Q 2020

Earnings per share (EUR per share)
Basic earnings per common share		0.18			0.61
Basic earnings per common share B		-			0.02
Diluted earnings per common share		0.18			0.61
Diluted earnings per common share B		-			0.02

Earnings per share calculation
Net income / (loss) attributable to owners of Aegon N.V.		383			1,270
Coupons on other equity instruments		(9	)		(10	)
Earnings attributable to common shares and common shares B		375			1,261

Earnings attributable to common shareholders		372			1,252
Earnings attributable to common shareholders B		3			9

Weighted average number of common shares outstanding (in millions)		2,044			2,039
Weighted average number of common shares B outstanding (in millions)		559			560

14. Borrowings



EUR millions	March 31, 2021		December 31, 2020
Capital funding		1,279		1,241
Operational funding		7,613		7,283
Total borrowings		8,892		8,524

During the first quarter of 2021, the operational funding increased by EUR 0.3 billion mainly due to the increase in Federal Home Loan Bank advances.


Unaudited

20 Condensed consolidated interim financial statements 1Q 2021 Results

15. Financial risks

There have been no significant changes in sensitivities for equity market risk, bond credit spreads and liquidity premium per December 31, 2020 as reported in Aegon’s 2020 Integrated Annual Report. Aegon’s sensitivity to interest rate risk has changed per March 31, 2021. This is the net result of the effect of the implementation of an interest rate macro hedge in the United States and the effect from the improvement of the LAT deficit in the Netherlands.

The table below shows the updated sensitivity per March 31, 2021 of the effect of a parallel shift in the yield curves on net result and shareholders’ equity.



EUR millions	March 31, 2021						December 31, 2020
	Estimated approximate effects on net result			Estimated approximate effects on shareholders’ equity			Estimated approximate effects on net result			Estimated approximate effects on shareholders’ equity
Parallel movements of yield curve
Immediate movements of yield curve, but not permanently
Shift up 100 basis points		(45	)		(3,173	)		187			(2,316	)
Shift down 100 basis points		(92	)		2,719			(462	)		2,064

16. Capital management and solvency

As at March 31, 2021, Aegon’s estimated capital position was:



Solvency II key figures
	March 31, 2021¹⁾			December 31, 2020
Amounts in EUR millions
Group Own Funds		18,810			18,582
Group SCR		9,676			9,473
Group Solvency II ratio		194	%		196	%

¹The Solvency II ratios are estimates, are not final until filed with the respective supervisory authority.

The table below provides the composition of Aegon’s Available Own Funds across Tiers:


	March 31, 2021 Available Own Funds		December 31, 2020 Available Own Funds

Tier 1 - unrestricted		13,101		12,971
Tier 1 - restricted		2,587		2,571
Tier 2		2,333		2,340
Tier 3		789		700
Total Available Own Funds		18,810		18,582

The table below provides the reconciliation from shareholders’ equity to Solvency II Own Funds:



Reconciliation Shareholders’ Equity - Own Funds
EUR millions	March 31, 2021			December 31, 2020

IFRS Shareholders’ Equity		22,035			22,815
IFRS adjustments for Other Equity instruments and non controlling interests		2,656			2,644
IFRS Group Equity		24,691			25,459
Solvency II revaluations and reclassifications		(8,396	)		(9,418	)
Transferability restrictions ¹		(1,832	)		(1,766	)
Excess of Assets over Liabilities		14,463			14,274
Availability adjustments		4,438			4,416
Fungibility adjustments		(92	)		(108	)
Available Own Funds		18,810			18,582

¹ This includes the transferability restriction related to the RBC CAL conversion methodology.

The Solvency II revaluations and reclassification mainly stem from the difference in valuation and presentation between IFRS-EU and Solvency II frameworks. The decrease of Solvency II revaluation and reclassifications is mainly driven by increasing interest rates during 1Q 2021, leading to lower revaluation reserves in Aegon US.


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 21

17. Commitments and contingencies

There have been no material changes in commitments and contingencies as reported in Aegon’s 2020 Integrated Annual Report.

18. Acquisitions/Divestments

On February 28, 2021, Aegon completed the divestment of Stonebridge, a UK-based provider of accident insurance products to Global Premium Holdings group, part of Embignell group. Under the terms of the agreement, Aegon sold Stonebridge for a consideration of approximately GBP 60 million, consisting of the purchase price and dividends related to the transaction. This excludes a contingent consideration of up to GBP 10 million. The transaction had no material impact on Aegon’s capital position and results.

19. Post reporting date events

On April 7, 2021, Aegon has taken note of an announcement issued that day by Vienna Insurance Group AG Wiener Versicherung Gruppe (VIG). The announcement issued by VIG reads as follows: “Acquisition of the Aegon entities prevented by Hungary for the moment. Vienna Insurance Group AG Wiener Versicherung Gruppe received a decree yesterday afternoon in which the Hungarian Ministry of the Interior announced that the intended acquisition by a foreign investor of the Aegon companies in Hungary is denied. As part of the approval process, Vienna Insurance Group has been in constructive talks with the responsible Hungarian Minister of Finance since January 2021. The decree is in contradiction with the course of the talks to date. Vienna Insurance Group expects that this issue will be resolved positively in the near future.” Aegon will continue to work with VIG to close the transaction.


Unaudited

22 Condensed consolidated interim financial statements 1Q 2021 Results

Disclaimers

Cautionary note regarding non-IFRS-EU measures

This document includes the following non-IFRS-EU financial measures: operating result, income tax and result before tax. These non-IFRS-EU measures are calculated by consolidating on a proportionate basis Aegon’s joint ventures and associated companies. The reconciliation of these measures to the most comparable IFRS-EU measure is provided in note 3 ‘Segment information’ of Aegon’s Condensed Consolidated Interim Financial Statements. Aegon believes that these non-IFRS-EU measures, together with the IFRS-EU information, provide meaningful supplemental information about the operating results of Aegon’s business including insight into the financial measures that senior management uses in managing the business.

Forward-looking statements

The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, could, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:

Changes in general economic and/or governmental conditions, particularly in the United States, the Netherlands and the United Kingdom;

Changes in the performance of financial markets, including emerging markets, such as with regard to:

–

The frequency and severity of defaults by issuers in Aegon’s fixed income investment portfolios;

–

The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and

–

The effects of declining creditworthiness of certain public sector securities and the resulting decline in the value of government exposure that Aegon holds;

Changes in the performance of Aegon’s investment portfolio and decline in ratings of Aegon’s counterparties;

Lowering of one or more of Aegon’s debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon’s ability to raise capital and on its liquidity and financial condition;

Lowering of one or more of insurer financial strength ratings of Aegon’s insurance subsidiaries and the adverse impact such action may have on the written premium, policy retention, profitability and liquidity of its insurance subsidiaries;

The effect of the European Union’s Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain;

Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;

Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;

Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness;

Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;

Catastrophic events, either manmade or by nature, including by way of example acts of God, acts of terrorism, acts of war and pandemics, could result in material losses and significantly interrupt Aegon’s business;

The frequency and severity of insured loss events;

Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegon’s insurance products;

Aegon’s projected results are highly sensitive to complex mathematical models of financial markets, mortality, longevity, and other dynamic systems subject to shocks and unpredictable volatility. Should assumptions to these models later prove incorrect, or should errors in those models escape the controls in place to detect them, future performance will vary from projected results;

Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations;

Changes in customer behavior and public opinion in general related to, among other things, the type of products Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations;

Customer responsiveness to both new products and distribution channels;

As Aegon’s operations support complex transactions and are highly dependent on the proper functioning of information technology, operational risks such as system disruptions or failures, security or data privacy breaches, cyberattacks, human error, failure to safeguard personally identifiable information, changes in operational practices or inadequate controls including with respect to third parties with which we do business may disrupt Aegon’s business, damage its reputation and adversely affect its results of operations, financial condition and cash flows;

The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegon’s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions;

Aegon’s failure to achieve anticipated levels of earnings or operational efficiencies, as well as other management initiatives related to cost savings, cash capital at Holding, gross financial leverage and free cash flow;

Changes in the policies of central banks and/or governments;

Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business;

Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegon’s products;

Consequences of an actual or potential break-up of the European monetary union in whole or in part, or the exit of the United Kingdom from the European Union and potential consequences if other European Union countries leave the European Union;

Changes in laws and regulations, particularly those affecting Aegon’s operations’ ability to hire and retain key personnel, taxation of Aegon companies, the products Aegon sells, and the attractiveness of certain products to its consumers;

Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which Aegon operates;

Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and the International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer (G-SII); and

Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, which may affect Aegon’s reported results, shareholders’ equity or regulatory capital adequacy levels.

This document contains information that qualifies, or may qualify, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation (596/2014). Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegon’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.


		Unaudited

Condensed consolidated interim financial statements 1Q 2021 Results 23

Corporate and shareholder information

Headquarters

Aegon N.V.

P.O. Box 85

2501 CB The Hague

The Netherlands

+ 31 (0) 70 344 32 10

aegon.com

Group Corporate Communications & Investor Relations

Media relations

+ 31 (0) 70 344 8344

[email protected]

Investor relations

+ 31 (0) 70 344 83 05

or 877 548 96 68 - toll free, USA only

[email protected]


Publication dates results

August 12, 2021		2Q 2021 Results

November 11, 2021		3Q 2021 Results

About Aegon

Aegon’s roots date back 175 years – to the first half of the nineteenth century. Since then, Aegon has grown into an international company, with businesses in the Americas, Europe and Asia. In the US, Aegon’s largest market, we operate under the Transamerica brand. Today, Aegon is one of the world’s leading financial services organizations, providing life insurance, pensions and asset management. Aegon has never lost sight of its purpose, to help people achieve a lifetime of financial security. More information: aegon.com.


Unaudited

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

Create E-mail Alert Related Categories

SEC Filings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Form 6-K AEGON NV For: May 12

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

You May Also Be Interested In

Create E-mail Alert Related Categories

Sign up for StreetInsider Free!

Free News Feed